This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It is often employed in the development of pharmaceuticals targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. Its structural features make it a valuable building block for creating compounds that interact with specific receptors or enzymes in the brain. Additionally, it has been explored in the design of potential therapeutic agents for conditions such as anxiety, depression, and epilepsy. Its trifluoromethyl group enhances its metabolic stability, making it a preferred choice in drug discovery processes. Researchers also investigate its role in optimizing pharmacokinetic properties of drug candidates, ensuring better efficacy and safety profiles.